文献速递糖尿病

遗传风险与1型糖尿病临床前阶段的转换

Genetic Risk and Transition Through Preclinical Stages of Type 1 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

研究在TrialNet基因分型参与者中评估T1D遗传风险评分GRS2及其HLA和非HLA组分、HLA-DR3和HLA-DR4单倍型及90个单核苷酸变异对三个糖尿病阶段转换的影响。结果显示GRS2与全部三个转换相关,HLA II类为主要贡献,支持将GRS2纳入以增强对临床前T1D进展的预测。

要点

  • GRS2与单抗体阳性到1期(HR 1.11)、1期到2期(HR 1.05)、2期到3期(HR 1.13)均相关。
  • HLA II类组分与全部三个转换相关,HLA I类组分和DR4与第一和第三转换相关。
  • HLA-DR3仅与2期到3期临床T1D的转换相关。

核心结论

  • 遗传因素影响临床前T1D每个阶段的转换,主要贡献来自HLA II类。
  • 结果支持将T1D GRS2纳入以增强对临床前T1D进展的预测。

研究设计与样本

  • 在TrialNet参与者中,使用TEDDY-T1DExomeChip阵列(Illumina HumanCoreExome Beadarray with custom content)进行基因分型。
  • 评估GRS2及其HLA和非HLA组分、HLA-DR3和HLA-DR4单倍型及90个单核苷酸变异对三个转换的影响。
  • 三个转换样本量:单确认抗体阳性到1期N=4314,1期到2期N=3066,2期到3期临床T1D N=2045。

主要发现

  • GRS2的HLA和HLA II类组分与全部三个转换相关。
  • HLA I类组分和HLA-DR4单倍型与单抗体阳性到1期及2期到3期转换相关,HLA-DR3仅与后者相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The influence of genetic factors on the transition through preclinical stages of type 1 diabetes (T1D) has not been studied. OBJECTIVE: Our aim was to evaluate the influence of genetic factors on transition through T1D stages. METHODS: In TrialNet participants who have been genotyped with the TEDDY-T1DExomeChip array (Illumina HumanCoreExome Beadarray with custom content), we evaluated the influence of the overall T1D genetic risk score (GRS2), its human leukocyte antigen (HLA) and non-HLA components, HLA-DR3 and HLA-DR4 haplotypes, and 90 single-nucleotide variations previously associated with islet autoimmunity and/or T1D on 3 transitions between diabetes stages: from single confirmed autoantibody positive to stage 1 (N = 4314), from stage 1 to stage 2 (N = 3066), and from stage 2 to stage 3 (clinical) T1D (N = 2045). RESULTS: The T1D GRS2 was associated with all 3 transitions with hazard ratios (HRs) of 1.11 (1.09-1.14) for single-autoantibody positivity to stage 1, HR 1.05 (1.03-1.08) for stage 1 to 2, and HR 1.13 (1.09-1.17) for stage 2 to 3 T1D. The T1D GRS2 HLA and HLA class II components were associated with all 3 transitions. The HLA class I component and the HLA-DR4 haplotype were associated with the transition from single-autoantibody positivity to stage 1 and from stage 2 to stage 3 T1D, while HLA-DR3 was associated only with the latter. CONCLUSION: Genetics influence transitions through each stage of preclinical T1D, with main contributions from HLA class II. These results increase our understanding of T1D development and support incorporating the T1D GRS2 to enhance the prediction of progression through the preclinical stages of T1D.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Steck AK, Parikh HM, Triolo TM, et al. Genetic Risk and Transition Through Preclinical Stages of Type 1 Diabetes. J Clin Endocrinol Metab. 2026. PMID: 40632818. doi:10.1210/clinem/dgaf392

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。